Dr. Allyson Berent graduated from Cornell University College of Veterinary Medicine in 2002 and completed a residency in veterinary internal medicine at the University of Pennsylvania in 2005, followed by a fellowship in interventional radiology and endourology at the University of Pennsylvania and Thomas Jefferson University. Since 2009, she serves as the director of the Interventional Endoscopy Service at the Animal Medical Center in NYC. Dr. Berent is the CSO of the Foundation for Angelman Syndrome Therapeutics and the Chief Operating Officer for GeneTx Biotherapeutics, developing a novel antisense olignonucleotide for the treatment of Angelman syndrome, as rare neurogenetic disorder.